A failed Congressional attempt to overhaul the regulation of lab-developed tests might hold the seeds of a better approach to the regulation of innovative technology, former US Food and Drug Administration Commissioner Scott Gottlieb said at the Food & Drug Law Institute (FDLI) annual conference in Washington, DC, on 17 May.
Gottlieb, who is now a senior fellow at the American Enterprise Institute, served as the FDA’s commissioner between 2017 and...